Biased research, aggressive sales, harmful drugs
The Health Policy Exchange
MAY 20, 2013
In this month's Georgetown University Health Policy seminar, we discussed two examples, anemia drugs and the diabetes drug rosiglitazone (Avandia) , which were prominently featured in recent articles by Peter Whoriskey in The Washington Post. The size of average doses would more than triple. Kenny Lin, MD Director, Robert L.
130 
Let's personalize your content